Literature DB >> 1400972

Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa.

L F Joyce1, J Downes, K Stockman, J H Andrew.   

Abstract

The antimicrobial susceptibilities of 100 clinical isolates of Pseudomonas aeruginosa to six antipseudomonal antibiotics were tested by five methods: the National Committee for Clinical Laboratory Standards (NCCLS) methods for broth microdilution, agar dilution, and agar disk diffusion; the Vitek Automicrobic System method (Vitek Systems, Hazelwood, Mo.); and the PDM Epsilometer test (E test) (AB Biodisk, Solna, Sweden). The E test results showed excellent correlation with agar dilution results, with over 90% agreement within 1 doubling dilution between the E test and reference agar dilution MICs for all antimicrobial agents tested. The E test results also showed good correlation with the results from the reference agar disk diffusion method, with 90 to 99% complete agreement and 100% essential agreement on categories for all antibiotics tested (essential agreement is the agreement obtained when minor discrepancies are ignored). Comparison of categories with the E test and broth microdilution methods, using the broth microdilution method as the reference method, gave only 59% complete agreement for gentamicin, with 28 minor discrepancies and 13 very major discrepancies. Some discrepancies were observed between results from the E test and broth methods for gentamicin, with the broth microdilution and Vitek methods giving higher MICs than the E test and other methods using agar. The most recent NCCLS guidelines for broth dilution testing have reduced the recommended levels of cation supplementation, which may enhance future agreement between results for the aminoglycosides and P. aeruginosa on broth and on agar. We found that the E test offers a simple, labor-efficient, and accurate method for MIC determination on an agar medium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400972      PMCID: PMC270503          DOI: 10.1128/jcm.30.10.2709-2713.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media.

Authors:  L B Reller; F D Schoenknecht; M A Kenny; J C Sherris
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

2.  Wide variability in Pseudomonas aeruginosa aminoglycoside results among seven susceptibility testing procedures.

Authors:  J L Staneck; S Glenn; J R DiPersio; P A Leist
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

3.  Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.

Authors:  R H Eng; S M Smith; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

4.  Error rates associated with the use of recently proposed breakpoints for testing Pseudomonas aeruginosa versus gentamicin, tobramycin, and amikacin by the standardized disk agar diffusion test.

Authors:  B F Woolfrey; J M Fox; C O Quall; R T Lally
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

5.  Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram.

Authors:  R B Clark; C C Sanders; C B Pakiz; M K Hostetter
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

6.  Cation components of Mueller-Hinton agar affecting testing of Pseudomonas aeruginosa susceptibility to gentamicin.

Authors:  M A Kenny; H M Pollock; B H Minshew; E Casillas; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

7.  Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.

Authors:  L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1969-09       Impact factor: 3.411

8.  Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.

Authors:  J A Washington; R J Snyder; P C Kohner; C G Wiltse; D M Ilstrup; J T McCall
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

9.  Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

10.  Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa.

Authors:  B F Woolfrey; J M Fox; C O Quall
Journal:  Am J Clin Pathol       Date:  1981-01       Impact factor: 2.493

View more
  21 in total

1.  In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test.

Authors:  H S Heine; M J England; D M Waag; W R Byrne
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Substrate spectrum extension of PenA in Burkholderia thailandensis with a single amino acid deletion, Glu168del.

Authors:  Hyojeong Yi; Karan Kim; Kwang-Hwi Cho; Oksung Jung; Heenam Stanley Kim
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

3.  Deletion mutations conferring substrate spectrum extension in the class A β-lactamase.

Authors:  Junghyun Hwang; Kwang-Hwi Cho; Han Song; Hyojeong Yi; Heenam Stanley Kim
Journal:  Antimicrob Agents Chemother       Date:  2014-07-21       Impact factor: 5.191

4.  Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa.

Authors:  G V Doern; A B Brueggemann; R Perla; J Daly; D Halkias; R N Jones; M A Saubolle
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

5.  Lethality of sortase depletion in Actinomyces oris caused by excessive membrane accumulation of a surface glycoprotein.

Authors:  Chenggang Wu; I-Hsiu Huang; Chungyu Chang; Melissa Elizabeth Reardon-Robinson; Asis Das; Hung Ton-That
Journal:  Mol Microbiol       Date:  2014-09-17       Impact factor: 3.501

6.  Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  B Balke; M Hogardt; S Schmoldt; L Hoy; H Weissbrodt; S Häussler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

7.  Evaluation of the E test for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from patients with long-term bladder catheterization.

Authors:  G Di Bonaventura; E Ricci; N Della Loggia; G Catamo; R Piccolomini
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

8.  Comparison of the Sceptor Pseudomonas Plus MIC Panel with agar dilution for susceptibility testing of Pseudomonas aeruginosa.

Authors:  L F Joyce; K Stockman; J Downes; J H Andrew
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

9.  Evaluation of E-Test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  E F Marley; C Mohla; J M Campos
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

10.  Antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from a Malaysian Hospital.

Authors:  Siva Gowri Pathmanathan; Nor Azura Samat; Ramelah Mohamed
Journal:  Malays J Med Sci       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.